Top news of the week: 08.02.2022.
Healthcare
Carl June: ‘We can now conclude that CAR-T cells can actually cure patients’
A decade after the first-ever patients were infused with CAR-T, at least two of them remain cancer free and their genetically modified cells still appear active, surveilling their blood for ...
The Cancer Moonshot Relaunched
Last week, I had the honor of attending the Biden Administration’s relaunch of the Cancer Moonshot at the White House. The Cancer Moonshot dates back to 2016, when then-Vice President ...
Welcome to Kannan's Climb to Fight Cancer Web Page
Symbolizing the team work needed to complete the mission to beat cancer, a team of cancer researchers, survivors, entrepreneurs from academic, biotech and pharma background are …
Preventing Pandemics by Reshaping Vaccine R&D
R&D advances delivered COVID-19 vaccines to the clinic quickly. To prevent the next pandemic, manufacturing and finance could matter more.
Investors: Will a Psychedelic Drug Take This Pharma Stock to the Next Level?
Algernon Pharmaceuticals plans to be the world's first company to test the psychedelic drug DMT in stroke patients, and it's close to achieving its goal.
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates
Collaboration focused on discovering novel ADCs for three targets by leveraging Mersana’s ADC expertise and the Dolasynthen platform with Janssen’s...
Welcome to Leslie J Williams Climb to Fight Cancer Web Page
Cecilia Gonzalo & Ignacio Fente In 2020 I accepted the challenge to raise funds to support the Climb to Fight Cancer by joining biotech journalist Luke Timmerman and a group of …